The Pan-American Health Organisation (PAHO) has stated that Venezuela has received its first batch of COVID-19 vaccines through the COVAX global vaccine facility intended for poor countries, Reuters news agency reported on Wednesday.
This comes after months of delays that the Venezuelan government attributed to US sanctions.
Venezuela has reportedly received 693,000 doses of Chinese biopharmaceutical company Sinovac Biotech Inc's (Nasdaq:SVA) COVID-19 vaccine, the first of a total of 11 million it will receive through COVAX, overseen by the GAVI alliance and the World Health Organisation.
So far, Venezuela has depended on Russia's Sputnik V COVID-19 vaccine and Chinese pharmaceutical company Sinopharm's shot to inoculate its population against COVID-19
An additional batch of Sputnik V COVID-19 doses has arrived this week in Venezuela, though authorities did not specify how many arrived.
According to PAHO estimates, about 3.3 million Venezuelans, or around 10% of the population, have been vaccinated.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses